January 09, 2025

New Member: Welcome in our cluster to Alcedis GmbH

New Member: Welcome in our cluster to Alcedis GmbH
Go back

Alcedis is a globally operating, leading full-service CRO with over 30 years of experience in clinical research. As a member of the Huma Group, they combine deep expertise with innovative AI-driven technologies to conduct clinical trials efficiently and accurately – from Phase I to market authorization, medical device projects, and real-world evidence. Their in-house competence centers for clinical operations, data management, and regulatory affairs drive advancements in drug and medical device development as well as patient care.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
BioMed X: Regional Strength for Global Women’s Health

BioMed X: Regional Strength for Global Women’s Health

It is a beacon in the Rhine-Neckar metropolitan region: The Heidelberg-based research company BioMed X is developing new approaches to drug development at the intersection of science and industry – currently, for example, through “XFem Labs,” a women’s health project funded by the Gates Foundation. Full Text in German below. BioMed X: Regionale Power für […]

read more
Strategische Investition in Deutschland: Roche weiht hochmodernes 90-Millionen-Euro-Distributionszentrum in Mannheim ein

Strategische Investition in Deutschland: Roche weiht hochmodernes 90-Millionen-Euro-Distributionszentrum in Mannheim ein

Mannheim, 23. März 2026 Zu den Downloads Mit einer Investition von 90 Millionen Euro stärkt Roche den Standort Mannheim als ein zentrales Drehkreuz im globalen Distributionsnetzwerk für Diagnostika des Unternehmens. Das neue Distributionszentrum für Europa umfasst eine Fläche von rund 16.300 Quadratmetern, das entspricht etwa zweieinhalb Fußballfeldern. Hochmoderne Automatisierungstechnik und nahtlos vernetzte IT- und Transportsysteme […]

read more
InnovationLab GmbH: German Cancer Research Center Expands Its Shareholder Base

InnovationLab GmbH: German Cancer Research Center Expands Its Shareholder Base

Heidelberg, March 18, 2026 – At yesterday’s meeting of the Board of Trustees of the German Cancer Research Center (DKFZ), the board decided to become the fifth shareholder of InnovationLab GmbH (iL). In addition to BASF SE and HEIDELBERG (Heidelberger Druckmaschinen AG), the Karlsruhe Institute of Technology (KIT) and the Ruprecht-Karls University of Heidelberg are […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp